• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Header Right

Search

  • Home
  • Expertise
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Executive Team
      • Study Management
    • History
    • Careers
    • Privacy policy / GDPR
  • Contact

Publications

Dinger Jürgen, Möhner Sabine, Heinemann Klaas, Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: Results from the extended INAS-SCORE study. Frontiers in Women's Health. 2020; Vol. 5: 1-8. 10.15761/FWH.1000178.
Download PDF: Jürgen-et-al.-2020_Results-from-the-extended-INAS-SCORE-study.pdf
Barnett Clare, Bauerfeind Anja, von Stockum Sophia, Grimes David A., Heinemann Klaas, Comparing the Cardiovascular Risk of Norethindrone Acetate & Levonorgestrel Pills: Is There a Difference? [10I]. Obstetrics & Gynecology. 2020; Volume 135 - Issue - p 94S. 10.1097/01.AOG.0000664136.96902.7e.
Bögemann Martin, Zagorska Aleksandra, Akumo Divine, El Hadad Laila, Pignot Marc, Using Data from a Sickness Fund Claims Database to Assess the Treatment Patterns and Healthcare Resource Utilization among Patients with Metastatic Renal Cell Carcinoma in Germany Urologia Internationalis. 2020; 10.1159/000509973.
Ständer Sonja, Ketz Miriam, Kossack Nils, Akumo Divine, Pignot Marc, Gabriel Sylvie, Chavda Rajeev, Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis. Acta Dermato-Venereologica. 2020; 100 (18): adv00309. 10.2340/00015555-3655.
Heinemann Klaas, Imthurn Bruno, Marions Lena, Gerlinger Christoph, Becker Kerstin, Möhner Sabine, Faustmann Thomas, Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study Advances in Therapy. 2020; 2528-2537. 10.1007/s12325-020-01331-z.
Möhner Sabine, Becker Kerstin, Lange Jens, von Stockum Sophia, Heinemann Klaas, Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study European Journal of Obstetrics &Gynecology and Reproductive Biology. 2020; 212 - 217. 10.1016/j.ejogrb.2020.05.049.
Dinger Jürgen, COCs containing dienogest and 30 μg ethinylestradiol may carry a higher VTE risk compared to corresponding preparations with levonorgestrel: A meta-analysis of four large cohort studies. Frontiers in Women's Health. 2020; Vol. 5: 1-6. 10.15761/FWH.1000175.
Download PDF: Jürgen-2020_COCs-containing-dienogest-and-30-μg-ethinylestradiol.pdf
Reed Suzanne, Do Minh Thai, Lange Jens, Koro Carol, Fox Michelle, Heinemann Klaas, Real world data on Nexplanon® procedure-related events: final results from the Nexplanon observational risk assessment study (NORA) Contraception. 2019; pii: S0010-7824(19)30131-3. 10.1016/j.contraception.2019.03.052.
Barnett Clare, Dinger Jürgen, Do Minh Thai, Heinemann Klaas, Unintended pregnancy rates differ according to combined oral contraceptive – results from the INAS-SCORE study Contraception & Reproductive Health Care. 2019; 1-4. 10.1080/13625187.2019.1629412.
Barnett Clare, Möhner Sabine, Do Minh Thai, Heinemann Klaas, Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study The European Journal of Contraception and Reproductive Health Care. 2018; page 1-5.
Heinemann Klaas, Pauls Karl, Drug Utilization Study on the Prescribing Indications for CPA/EE (Cyproterone acetate 2mg in combination with Ethinylestradiol 35mcg) in 5 European Countries Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue S2, Pages 1-674.
Hagemann Christine, Heinemann Klaas, Möhner Sabine, Safety and efficacy of intrauterine devices: Baseline characteristics of 32,022 study participants from the EURAS-LCS12 study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.
Bauerfeind Anja, Möhner Sabine, Do Minh Thai, Heinemann Klaas, The Influence of Women’s Educational Level on Unintended Pregnancy Rates amongst Users of Combined Oral Contraceptives Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.
Heinemann Klaas, Dinger Jürgen, Do Minh Thai, Franke Christian, Unintended Pregnancies in Users of Different Combined Oral Contraceptives – Final results from the INAS-SCORE Study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.
Heinemann Klaas, Dinger Jürgen, Do Minh Thai, Franke Christian, Cardiovascular Safety in Users of Different Combined Oral Contraceptives – Final results from the INAS-SCORE Study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 14
  • Go to Next Page »

sidebar

Search our Publications

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2021 ZEG Berlin

Impressum

Website by Laura Yeffeth

This site uses cookies: Find out more.